Novel oximes

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 997-1021

  Kuca, Kamil ^a,b   Musilek, Kamil ^b   Jun, Daniel ^a,b   Bajgar, Jiri ^a   Kassa, Jiri ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72049117857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00066-3     Document Type: Chapter

References (121)

1. Acharya, J., Gupta, A.K., Mazumder, A., Dubey, D.K. (2008a). In vitro reactivation of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing methoxy ether linkages. Toxicol. In Vitro22: 525-30.
2. Acharya, J., Gupta, A.K., Dubey, D.K., Raza, S.K. (2008b). Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase. Eur. J. Med. Chem. doi:10.1016/jejmech.2008.02.029.
3. Acharya, J., Gupta, A.K., Mazumder, A., Dubey, D.K. (2008c) In-vitro regeneration of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing xylene linker. Eur. J. Med. Chem. doi:10.1016/jejmech.2008.02.020.
4. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38:151-216.
5. Bajgar J. Laboratory diagnosis of organophosphates/nerve agent poisoning. Klin. Bioch. Metab. 2005, 13:40-47.
6. Bajgar J., Fusek J., Kuca K., Bartosova L., Jun D. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini Rev. Med. Chem. 2007, 7:461-466.
7. Benko B., Kalasz H., Ludányi K., Petroianu G., Kuca K., Darvas F., Tekes K. In vitro and in vivo metabolisms of K-48. Anal. Bioanal. Chem. 2007, 389:1243-1247.
8. Berman H.A., Leonard K. Ligand exclusion on acetylcholinesterase. Biochemistry 1990, 29:10640-10649.
9. Black R.M., Clark R.J., Read R.W., Reid M.T.J. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products. J. Chromatogr. 1994, 662:301-321.
10. Bolz F., Dudonis K.J., Schulz D.P. The Counterterrorism Handbook -Tactics, Procedures, and Techniques 2002, CRC Press, Boca Raton, FL.
11. Bourne Y., Taylor P., Radic Z., Marchot P. Structural insight into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J 2003, 22:1-12.
12. Bregovec I., Maksimovic M., Kilibarda V., Binenfeld Z. Adamantane derivatives as potential reactivators of acetylcholinesterase inhibited by organophosphorous compounds. Acta Pharm. 1992, 42:251-253.
13. Cabal J., Kuca K., Kassa J. Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Bas. Clin. Pharmacol. Toxicol. 2004, 95:81-86.
14. Calic M., Lucic-Vrdoljak A., Radic B., Jelic D., Jun D., Kuca K., Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun-and soman-poisoned mice and their cytotoxicity. Toxicology 2006, 219:85-96.
15. Carvalho I., Miller J. Synthesis of 1-methyl-2-hydroxyiminomethyl-aryl-pyridinium salts with potential as acetyl-cholinesterase reactivators. Heterocycl. Commun. 1995, 1:403-410.
16. Chennamaneni S.R., Vobalaboina V., Garlapati A. Quaternary salts of 4,30 and 4,40bis-pyridinium monooximes: synthesis and biological activity. Bioorg. Med. Chem. Lett. 2005, 15:3076-3080.
17. Csermely T., Petroianu G., Kuca K., Furesz J., Darvas F., Gulyas Z., Laufer R., Kalasz H. TLC of quaternary pyridinium aldoximes, antidotes of organophosphorus esterase inhibitors. JPC 2007, 20:39-42.
18. Da Silva A.P., Farina M., Franco J.L., Dafre A.L., Kassa J., Kuca K. Temporal effects of newly developed oximes (K027, K048) on malathion-induced acetylcholinesterase inhibition and lipid peroxidation in mouse prefrontal cortex. Neurotoxicology 2008, 29:184-189.
19. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994, 14:317-331.
20. Deljac V., Deljac A., Mesic M., Kilibarda V., Maksimovic M., Binenfeld Z. Reactivators of AChE inhibited by organophosphorous compounds. Butenylenic and tetramethylenic heterocyclic oximes. IV. Acta Pharm. 1992, 42:173-179.
21. Ekström F., Pang Y.P., Boman M., Artursson E., Akfur C., Börjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem. Pharmacol. 2006, 72:597-607.
22. Ekström F.J., Astot C., Pang Y.P. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes. Clin. Pharmacol. Ther. 2007, 82:282-293.
23. Ellman G.L., Courtney D.K., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
24. Eyer P., Hagedorn I., Klimmek R., Lippstreu P., Löffler M., Oldiges H., Spöhrer U., Steidl I., Szinicz L., Worek F. HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch. Toxikol. 1992, 66:603-621.
25. GoffD.A., Koolpe G.A., Kelson A.B., Vu H.M., Taylor D.L., Bedford C.D., Musallam H.A., Koplovitz I., Harris R.N. Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 4. Effect of various side-chain substituents on therapeutic activity against anticholinesterase intoxication. J. Med. Chem. 1991, 34:1363-1368.
26. Gyenge M., Kalasz H., Petroianu G., Laufer R., Kuca K., Tekes K. Measurement of K-27, an oxime-type cholinesterase reactivator by high performance liquid chromatography with electrochemical detection from different biological samples. J. Chromatogr. A 2007, 1161:146-151.
27. Halamek E., Kobliha Z., Pitschmann V. Analysis of Chemical Warfare Agents 2007, University of Defence, Vyskov, Czech Republic. 1st edition.
28. Hampl F., Mazac J., Liska F., Srogl J., Kabrt L., Suchanek M. Quaternary heteroarenium aldoximes as catalysts for cleavage of phosphate esters. Collect. Czech. Chem. Commun. 1995, 60:883-893.
29. Harel M., Schalk I., Ehret-Sabatier L., Bouet F., Goeldner M., Hirth C., Axelsen P.H., Silman I., Sussman J.L. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl Acad. Sci. USA 1993, 90:9031-9035.
30. Heath D.F. Organophosphorus Poisons: Anticholinesterases and Related Compounds. 1961, Pergamon Press, Oxford.
31. Hrabinova M., Musilek K., Jun D., Kuca K. New group xylene linker containing acetylcholinesterase reactivators as antidotes against nerve agent cyclosarin. J. Enzyme Inhib. Med. Chem. 2006, 21:515-519.
32. Hsiao, L.Y.Y., Musallam, H.A. (1992) U.S. Patent Appl. US 5130438.
33. Jun D., Kuca K., Picha J., Koleckar V., Marek J. Potency of novel oximes to reactivate sarin inhibited human cholinesterases. Drug Chem. Toxicol. 2008, 31:1-9.
34. Kalasz H., Hasan M.Y., Sheen R., Kuca K., Petroianu G.A., Ludany K., Gergely A., Tekes K. HPLC analysis of K-48 concentration in plasma. Anal. Bioanal. Chem. 2006, 385:1062-1067.
35. Kassa J., Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum. Exp. Toxicol. 1999, 18:560-565.
36. Kassa J., Humlicek V. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice. Drug Chem. Toxicol. 2008, 31:127-135.
37. Kassa J., Kuca K., Cabal J., Paar M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vitro and in vivo methods. J. Toxicol. Environ. Health 2006, 69:1875-1882.
38. Kassa J., Jun D., Kuca K. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin and tabun-poisoned rats. J. Enzyme Inhib. Med. Chem. 2007, 22:297-300.
39. Kassa J., Karasova J., Musilek K., Kuca K. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 2008, 243:311-316.
40. Kim T.H., Kuca K., Jun D., Jung Y.S. Design and synthesis of new bis-pyridinium oximes as cyclosarin-inhibited acetylcholinesterase reactivators. Bioorg. Med. Chem. Lett. 2005, 15:2914-2917.
41. Kim T.H., Oh K.A., Park N.J., Lim Y.J., Yum E.K., Jung Y.S. Reactivation study of pyridinium oximes for acetylcholinesterases inhibited by paraoxon or DFP. J. Appl. Biomed. 2006, 4:67-72.
42. Koolpe G.A., Lovejoy S.M., GoffD.A., Lin K.Y., Leung D.S., Bedford C.D., Musallam H.A., Koplovitz I., Harris R.N. Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 5. Structure-activity relationships for side-chain nitro-, sulfone-, amino-, and aminosulfonyl-substituted analogues for therapy against anticholinesterase intoxication. J. Med. Chem. 1991, 34:1368-1376.
43. Kovacevic, V., Maksimovic, M., Deljac, V., Binenfeld, Z. (1989a). The efficacy of 1,10-(1,4-buten)-bis-(4-hydroxyiminomethyl-pyridinium) dibromide in the treatment of organophosphate poisoning. Acta Pharm.39: 167-70.
44. Kovacevic, V., Maksimovic, M., Pantelic, D., Vojvodic, V., Binenfeld, Z. (1989b). Protective and reactivating effects of HI-6 PAM-2 mixture in rats with nerve chemical warfare agents (nerve CWA). Acta Pharm.39: 161-5.
45. Kuca K., Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 2003, 18:529-535.
46. Kuca K., Kassa J. Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent. Hum. Exp. Toxicol. 2004, 23:167-171.
47. Kuca K., Patocka J. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J. Enzyme Inhib. Med. Chem. 2004, 19:39-43.
48. Kuca, K., Bielavsky, J., Cabal, J., Kassa, J. (2003a). Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett.13: 3545-7.
49. Kuca, K., Bielavsky, J., Cabal, J., Bielavska, M. (2003b). Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett.44: 3123-5.
50. Kuca, K., Patocka, J., Cabal, J. (2003c). Reactivation of organophosphate inhibited acetylcholinesterase activity by a, u-bis-(4-hydroxyiminomethylpyridinium)alkanes in vitro. J. Appl. Biomed.1: 207-11.
51. Kuca, K., Cabal, J., Patocka, J., Kassa, J. (2004a). Synthesis of bisquaternary symmetric -c, d-bis(2-hydroxyiminomethyl-pyridinium)alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett. Org. Chem.1: 84-6.
52. Kuca, K., Picha, J., Cabal, J., Liska, F. (2004b). Synthesis of the three monopyridinium oximes and evaluation of their potency to reactivate acetylcholinesterase inhibited by nerve agents. J. Appl. Biomed.2: 51-6.
53. Kuca, K., Cabal, J., Patocka, J., Dohnal, V. (2004c). Quaternary heteroarenium salts as the competitive inhibitors of the brain acetylcholinesterase. Lett. Drug Des. Disc.1: 97-100.
54. Kuca, K., Cabal, J., Musilek, K., Jun, D., Bajgar, J. (2005a). Effective bisquaternary reactivators of tabun-inhibited AChE. J. Appl. Toxicol.25: 491-5.
55. Kuca, K., Cabal, J., Kassa, J. (2005b). In vitro reactivation of sarin-inhibited brain acetylcholinesterase from various species by various oximes. J. Enzyme Inhib. Med. Chem.20: 227-32.
56. Kuca, K., Cabal, J., Jun, D., Kassa, K., Bartosova, L., Kunesova, G. (2005c). In vitro reactivation potency of some acetylcholinesterase reactivators against sarin and cyclosarin-induced inhibitions. J. Appl. Toxicol.25: 296-300.
57. Kuca, K., Cabal, J., Bajgar, J., Jun, D. (2005d). In vitro searching for a new potent reactivator of acetylcholinesterase inhibited by nerve agent VX. Lett. Drug Des. Disc.2: 23-5.
58. Kuca K., Jun D., Kim T.H., Cabal J., Jung Y.S. In vitro evaluation of new acetylcholinesterase reactivators as causal antidotes against tabun and cyclosarin. Bull. Korean Chem. Soc. 2006, 27:395-398.
59. Kuca, K., Jun, D., Bajgar, J. (2007a). Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem. Toxicol.30: 31-40.
60. Kuca, K., Musilek, K., Stodulka, P., Marek, J., Hanusova, P., Jun, D., Hrabinova, M., Kassa, J., Dolezal, B. (2007b). Twelve different HI-6 salts and their potency to reactivate cyclosarin inhibited AChE in vitro. Lett. Drug Des. Disc.4: 510-12.
61. Kuca, K., Musilek, K., Paar, M., Jun, D., Stodulka, P., Hrabinova, M., Marek, J. (2007c). Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide -a new nerve agent reactivator. Molecules12: 1964-72.
62. Kuca, K., Cabal, J., Jun, D., Musilek, K. (2007d). In vitro reactivation potency of cetylcholinesterase reactivators -K074 and K075-to reactivate tabun-inhibited human brain cholinesterases. Neurotoxicol. Res.11: 101-6.
63. Lorke D.E., Hasan M.Y., Nurulain S.M., Sheen R., Kuca K., Petroianu G.A. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the brain: comparison with obidoxime. J. Appl. Toxicol. 2007, 27:482-490.
64. Lorke, D.E., Hasan, M.Y., Arafat, K., Kuca, K., Musilek, K., Schmitt, A., Petroianu, G.A. (2008a). In vitro oxime reactivation of red blood cell acetylcholinesterase inhibitied by diisopropyl-fluorophosphate (DFP). J. Appl. Toxicol.28: 422-9.
65. Lorke, D.E., Kalasz, H., Petroianu, G.A., Tekes, K. (2008b). Entry of oximes into the brain: a review. Curr. Med. Chem.15: 743-53.
66. Lundy P.M., Raveh L., Amitai G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev. 2006, 25:231-243.
67. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58:51-66.
68. Marrs T.C., Maynard R.L., Sidell F.R. Chemical Warfare Agents. Toxicology and Treatment 1996, Wiley & Sons, Chichester, UK, J.
69. Mesic M., Deljac A., Deljac V., Binenfeld Z. Reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Imidazole derivatives II. Acta Pharm. 1991, 41:203-210.
70. Mesic M., Deljac A., Deljac V., Binenfeld Z., Maksimovic M., Kilibarda V. Synthesis of reactivators inhibited by organophosphorus compounds. Imidazole derivatives III. Acta Pharm. 1992, 42:169-172.
71. Mesic M., Roncevic R., Radic B., Fajdetic A., Binenfeld Z. Reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Imidazole derivatives. V. Acta Pharm. 1994, 44:145-150.
72. Millard C.B., Kryger G., Ordentlich A., Greenblatt H.M., Harel M., Raves M.L., Segall Y., Barak D., Shafferman A., Silman I., Sussman J.L. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry 1999, 38:7032-7039.
73. Musilek K., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J. Enzyme Inhib. Med. Chem. 2005, 20:409-415.
74. Musilek, K., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2006a). Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against autyrifos-inhibited acetylcholinesterase. Biorg. Med. Chem. Lett16: 622-7.
75. Musilek, K., Lipka, L., Racakova, V., Kuca, K., Jun, D., Dohnal, V., Dolezal, V. (2006b). New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem. Papers60: 48-51.
76. Musilek, K., Holas, O., Hambalek, J., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2006c). Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun-and paraoxon-inhibited acetylcholinesterase. Lett. Org. Chem.3: 831-5.
77. Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2006d). Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Biorg. Med. Chem. Lett.16: 5673-6.
78. Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V., Dolezal, M. (2007a). Synthesis of the novel series of asymmetrical bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. J. Enzyme Inhib. Med. Chem.22: 425-32.
79. Musilek, K., Kuca, K., Jun, D., Dolezal, M. (2007b). In vitro reactivation potency of bispyridinium (E)-but-2-ene linked acetylcholinesterase reactivators against tabun-inhibited acetylcholinesterase. J. Appl. Biomed.5: 25-30.
80. Musilek, K., Holas, O., Kuca, K., Jun, D., Dohnal, V., Opletalova, V., Dolezal, M. (2007c). Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker -synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Biorg. Med. Chem. Lett.17: 3172-6.
81. Musilek, K., Kuca, K., Dohnal, V., Jun, D., Marek, J., Koleckar, V. (2007d). Two step synthesis of non-symmetric reactivator of acetylcholinesterase. Molecules12: 1755-61.
82. Musilek, K., Holas, O., Jun, D., Dohnal, V., Gunn-Moore, F., Opletalova, V., Dolezal, M., Kuca, K. (2007e). Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker -preparation and reactivation of tabun and paraoxon-inhibited acetylcholinesterase. Biorg. Med. Chem.15: 6733-41.
83. Musilek, K., Jun, D., Cabal, J., Kassa, J., Gunn-Moore, F., Kuca, K. (2007f). Design of a potent reactivator of tabun-inhibited acetylcholinesterase -synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-e ne dibromide (K203). J. Med. Chem.50: 5514-18.
84. Musilek K., Holas O., Kuca K., Jun D., Dohnal V., Opletalova V., Dolezal M. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun-and paraoxon-inhibited acetylcholinesterase. J. Enzyme Inhib. Med. Chem. 2008, 23:70-76.
85. Odzak R., Calic M., Hrenar T., Primozic I., Kovarik Z. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase. Toxicology 2007, 233:85-96.
86. Oh K.A., Park N.J., Park N.S., Kuca K., Jun D., Jung Y.S. Determination of reactivation potency for DFP-and paraoxon-inhibited acetylcholinesterases by pyridinium oximes. Chem. Biol. Interact. 2008, 175:1-3. 365-7.
87. 2 linkers between pyridinium rings and their reactivity against VX. Biorg. Med. Chem. Lett. 2006, 16:4852-4855.
88. Ohta H., Ohmori T., Suzuki S., Ikegaya H., Sakurada K., Takatori T. New safe method for preparation of sarin-exposed human erythrocytes acetylcholinesterase using non-toxic and stable sarin analogue isopropyl p-nitrophenyl methylphosphonate and its application to evaluation of nerve agent antidotes. Pharm. Res. 2006, 23:2827-2833.
89. Okuno S., Sakurada K., Ohta H., Ikegaya H., Kazui Y., Akutsu T., Iwadate K. Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS. Toxicol. Appl. Pharmacol. 2008, 227:8-15.
90. Pang Y.-P., Brimijoin S. U.S. Pat. Appl. 1999, US 5929093.
91. Pang Y.P., Kollmeyer T.M., Hong F., Lee J.C., Hammond P.I., Haugabouk S.P., Brimijoin S. Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem. Biol. 2003, 10:491-502.
92. Patocka J. Military Toxicology 2004, Czech Republic, Grada Publishing As. (In Czech), Praha. 1st edition.
93. Patocka J., Cabal J., Kuca K., Jun D. Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus esters: in vitro kinetics and thermodynamics. J. Appl. Biomed. 2005, 2:91-99.
94. Petroianu G.A., Kalasz H. Comparison of the ability of pyridinium aldoximes to reactivate human RBC cholinesterases inhibited by ethyl-and methyl-paraoxon. Curr. Org. Chem. 2007, 11:1624-1634.
95. Petroianu, G.A., Nurulain, S.M., Nagelkerke, N., Al-Sultan, M.A., Kuca, K., Kassa, J. (2006a). Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J. Appl. Toxicol.26: 262-8.
96. Petroianu, G.A., Arafat, K., Kuca, K., Kassa, J. (2006b). Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J. Appl. Toxicol.26: 64-71.
97. Petroianu, G.A., Arafat, K., Nurulain, S.M., Kuca, K., Kassa, J. (2007a). In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon. J. Appl. Toxicol.27: 168-75.
98. Petroianu, G.A., Lorke, D.E., Hasan, M.Y., Adem, A., Sheen, R., Nurulain, S.M., Kalasz, H. (2007b). Paraoxon has only a minimal effect on pralidoxime brain concentration in rats. J. Appl. Toxicol.27: 350-7.
99. Petroianu, G.A., Nurulain, S.M., Nagelkerke, N., Shafiullah, M., Kassa, J., Kuca, K. (2007c). Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J. Appl. Toxicol.27: 453-7.
100. Petrova I., Bielavsky J. An overview of syntheses of cholinesterase reactivators from 1980 to 1992. Voj. Zdrav. Listy 2001, 70:63-73. Czech.
101. Picha J., Kuca K., Kivala M., Kohout M., Cabal J., Liska F. New group of monoquaternary reactivators of the acetylcholinesterase inhibited by nerve agents. J. Enzyme Inhib. Med. Chem. 2005, 20:233-237.
102. Poziomek E.J., Hackley B.E., Steinberg G.M. Pyridinium aldoximes. J. Org. Chem. 1958, 23:714-717.
103. Primozic I., Odzak R., Tomic S., Simeon-Rudolf V., Reiner I. Pyridinium, imidazolium, and quinucludinium oximes: synthesis, interaction with native and phosphylated cholinesterases, and antidotes against organophosphorus compounds. J. Med. Def. Chem. 2004, 2:1-30.
104. Racakova V., Jun D., Opletalova V., Kuca K. Reactivation of acetycholinesterase inhibited by pesticide chlorpyrifos. J. Appl. Biomed. 2006, 4:147-151.
105. Rotenberg J.S., Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics 2003, 112:648-658.
106. Sakurada K., Matsubara K., Shimizu K., Shiono H., Seto Y., Tsuge K., Yoshino M., Sakai I., Mukoyama H., Takatori T. Pralidoxime iodide (2-Pam) penetrates across the blood-brain barrier. Neurochem. Res. 2003, 28:1401-1407.
107. Schumacher M., Camp S., Maulet Y., Newton M., MacPhee-Quigley K., Taylor S.S., Friedmann T., Taylor P. Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature 1986, 319:407-409.
108. Sikder A.K., Ghosh A.K., Jaiswal D.K. Quaternary salts of 3,30-bis-pyridinium monooximes: synthesis and biological activity. J. Pharm. Sci. 1993, 82:258-261.
109. Singh H., Moorad-Doctor D., Ratcliffe R.H., Wachtel K., Castillo A., Garcia G.E. A rapid cation-exchange HPLC method for detection and quantification of pyridinium oximes in plasma and tissue. J. Anal. Toxicol. 2007, 31:69-74.
110. Skrinjaric-Spoljar M., Burger N., Lovric J. Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme. J. Enzyme Inhib. 1999, 14:331-341.
111. Srinivas Rao C., Venkateswarlu V., Achaiah G. Quaternary salts of 4,30 and 4,40 bis-pyridinium monooximes. Part 2: Synthesis and biological activity. Bioorg. Med. Chem. Lett. 2006, 16:2134-2138.
112. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991, 253:872-879.
113. Taylor P. The Pharmacological Basis of Therapeutics 1996, McGraw Hill, New York. J.G. Hardman, L.E. Limbird (Eds.).
114. Tekes K., Hasan M.Y., Sheen R., Kuca K., Petroianu G., Ludanyi K., Kalasz H. HPLC determination of the serum concentration of K-27, a novel oxime-type cholinesterase reactivator. J. Chromatogr. A 2006, 1122:84-87.
115. Tu A.T. Overview of sarin terrorist attacks in Japan. ACS Symposium Series 2000, 745:304-317.
116. Watson, A., Bakshi, K., Opresko, D., Young, R., Hauschild, V., King, J. (2006). Cholinesterase inhibitors as chemical warfare agents: community preparedness guidelines. In Toxicology of Organophosphate and Carbamate Compounds (R.C. Gupta, ed.), pp. 47-68. Academic Press, Amsterdam.
117. Whiteley C.G., Ngwenya D.S. Protein ligand interactions 7 halogenated pyridinium salts as inhibitors of acetylcholinesterase from electrophorus electricus. Biochem. Mol. Biol. Int. 1995, 36:1107-1116.
118. Worek F., Kirchner T., Backer M., Szinicz L. Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol. 1996, 70:497-503.
119. Worek F., Reiter G., Eyer P., Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch. Toxicol. 2002, 76:523-529.
120. Yang G.Y., Yoon J.H., Seong C.M., Park N.S., Jung Y.S. Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull. Korean Chem. Soc. 2003, 24:1368-1370.
121. 2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase. Bioorg. Med. Chem. 2007, 15:7704-7710.